Synogist

Were you looking for more information about Synagis? Synogist is a common misspelling of Synagis.
 
Synagis® (palivizumab) is a medication that is available by prescription only and helps prevent serious complications from respiratory syncytial virus (RSV) in infants and children age 24 months and younger. This medicine works by binding to RSV, preventing the virus from multiplying. It comes as an injection that is given once a month during the RSV season, which is usually from November to April.
 
To help ensure a safe treatment process, tell your child's healthcare provider about any other existing medical problems (such as a clotting or bleeding disorder), as well as any other medications, vitamins, or supplements your child is taking.
 
(Click Synagis for more information, including side effects to look out for during treatment and details on when and how the medication is administered. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by: Susan Lakey, PharmD, MPH, BCPP
Last reviewed by: Kristi Monson, PharmD